Wanrudee Isaranuwatchai

Associate Professor (status appointment)

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Wanrudee Isaranuwatchai is an Associate Professor at the University of Toronto, Canada. Her research focuses on public health, health economics, and health technology assessment, with recent publications addressing topics such as telemedicine reimbursement models, infectious disease modeling, and the cost-effectiveness of health interventions. She is actively involved in international collaborations aimed at enhancing global health security and has contributed significantly to understanding health resource allocation in various contexts.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Yot Teerawattananon

Visiting Professor

National University Singapore Saw Swee Hock School of Public Health

SINGAPORE

View details

Chris Painter

University of Oxford

UNITED KINGDOM

View details

Natasha Howard

Associate Professor

London School of Hygiene and Tropical Medicine Faculty of Public Health and Policy

UNITED KINGDOM

View details

Anthony Culyer

professor

University of York

UNITED KINGDOM

View details

Jodie McVernon

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wanrudee Isaranuwatchai

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

The Physical Activity at Work (PAW) Program in Thai Office Workers: Mixed Methods Process Evaluation Study

Telemedicine Public Reimbursement Models for National and Subnational Jurisdictions: Scoping Review

Enhancing global health security responses through greater inclusion of the global south in infectious disease modelling

Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?

The relative importance of severity and rarity criteria in health resource allocation: an umbrella review

Fifteen Lessons from Fifteen Years of the Health Intervention and Technology Assessment Program in Thailand

International Partnerships to Develop Evidence-informed Priority Setting Institutions: Ten Years of Experience from the International Decision Support Initiative (iDSI)

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic

What Can We Learn From Others to Develop a Regional Centre for Infectious Diseases in ASEAN? Comment on "Operationalising Regional Cooperation for Infectious Disease Control: A Scoping Review of Regional Disease Control Bodies and Networks"

Estimating the potential overdiagnosis and overtreatment of acute appendicitis in Thailand using a secondary data analysis of service utilization before, during and after the COVID-19 lockdown policy

What are the impacts of increasing cost-effectiveness Threshold? a protocol on an empirical study based on economic evaluations conducted in Thailand

Cost-Utility Analysis of the Ontario Fracture Screening and Prevention Program

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma

The emergency department as a setting‐specific opportunity for population‐based hepatitis C screening: An economic evaluation

Collaborators (5)

Yot Teerawattananon

Chris Painter

Natasha Howard

Anthony Culyer

Jodie McVernon

Make your next move.